Distinguished Speaker Seminars
Please note: Registration is free. Remember to check “autosubscribe” when registering to automatically sign up for future seminars. Also, please bookmark our website to check for future speakers. Important: For the best viewing experience, Google Chrome is the recommended browser. Firefox and Safari also will work. Recordings of recent seminars are posted below.
DISTINGUISHED SPEAKER SEMINAR
June 9 - 11 a.m. EDT - Chen Liu, MD, PhD, chair and professor of pathology, Yale University School of Medicine
"Molecular Profiling Liver Disease"
June 23 - 11 a.m. EDT - Kamel Khalili PhD, Laura H. Carnell professor, Department of Neuroscience, Chair and Professor, Department of Microbiology, Immunology and Inflammation, Temple University.
TBD - 11 a.m. - Keith R. Jerome, MD, PhD, Professor, Vaccine and Infectious Disease Division
“New humanized mouse models for HBV gene editing"
RECENT SEMINARS
April 1 - 11 a.m. EDT - 2021 Blumberg Prize Recipient, D. Lorne Tyrrell, MD, Department of Medical Microbiology and Immunology, University of Alberta.
A recording will be posted shortly!
March 31 - 9 a.m. - Peter Leedman, MBBS, PhD, FRACP, FAHMS, Director of the Harry Perkins Institute of Medical Research, Professor of Medicine at the University of Western Australia
"The rise and rise of RNA therapeutics for liver disease"
A recording will be posted shortly!
March 24 - 11 a.m. - Drew Weissman, MD, PhD, Roberts Family Professor in Vaccine Research, University of Pennsylvania Perelman School of Medicine.
“Nucleoside-Modified mRNA-LNP Therapeutics”
A recording will be posted shortly!
Dec. 2 - 11 a.m. - Laura Bergner, PhD, Research Associate at the Institute of Biodiversity, Animal Health & Comparative Medicine, University of Glasgow
"The evolutionary history of mammalian deltaviruses: what can we learn about the origins of HDV?"
A recording is posted here.
Oct. 14 - 3 p.m. EDT - Harvey Alter, PhD, Nobel Prize Recipient, Bruce Witte Lecture (online)
A recording is posted here.
Aug. 19 - 11 a.m. - Dr. Barbara Rehermann, MD, Senior Investigator, National Institutes of Health.
"Role of Liver-Resident Immune Cells in Hepatitis B and D Disease and Treatment"
A recording is posted here.
July 29- 11 a.m. - Randall Hyer, MD, PHD, MPH, Senior Vice President, Moderna, Inc.
"The Beginning and End of COVID-19."
A recording is posted here.
July 22 - 11 a.m. - Philip S. Low, Ph.D., Distinguished Professor of Chemistry-Biochemistry at Purdue University.
“Targeted Immunotherapies for Viral Diseases."
A recording is posted here.
June 17 - 11 a.m. EDT - Maura Dandri, Ph.D. Professor, University of Hamburg, Germany
"Stopping a murderer: factors affecting the HBV cccDNA"
A recording is posted here.
April 30 - 9 a.m. EDT - Wenhui Li, Ph.D.
Investigator, National Institute of Biological Sciences (NIBS) Beijing, China
A recording is posted here.
March 18 - 11 a.m. EDT - Lei Wei, Ph.D., Fellow, Department of Molecular Biology, Princeton University
"Making a murderer - Formation of Hepatitis B virus (HBV) Genomic cccDNA"
A recording is posted here.
Feb. 4, 2021 - Aleem Siddiqui, Ph.D., Division of Infectious Diseases and Global Public Health, University of California, San Diego
"Regulation of HBV/HCV infection by N6-methyladenosine modification"
A recording is posted here.
Jan. 21, 2021 - Ronald T. Hay, Ph. D., Centre for Gene Regulation and Expression, University of Dundee
"Molecular basis of arsenic treatment for acute promyelocytic leukaemia"
A recording is posted here.
Jan. 14, 2021 - Emilio A. Emini, Ph.D., FCPP, FAAM, Director TB and HIV Program Bill & Melinda Gates Foundation
"Controlling the Global HIV and TB Epidemics: Challenges and Opportunities"
Co-hosted by the Pennsylvania Drug Discovery Institute
A recording is posted here.
Dec. 10, 2020 - Dongfang Liu, MBBS, Ph.D, Professor of Pathology, Rutgers N.J. School of Medicine
"Natural Killer (NK) cells from basic immunobiology to clinical application"
A recording is posted here.
Dec. 3 - Stephan Urban, Ph.D., Department of Infectious Diseases, Heidelberg University Hospital
"Inhibitor of entry as a therapeutic for hepatitis B and D"
A recording will be posted here shortly.
Oct. 1 - Nicholas van Buuren, Ph.D., Gilead Sciences
"Integrated HBV DNA: Investigation of the Architecture and Potential Clinical Implications."
A recording is posted here.
Sept. 13 - Rudolf K. Beran, Ph.D., Gilead Sciences
“Characterizing the interplay between hepatitis B virus X protein and Smc5/6."
A recording is posted here.
Aug. 13 - V. Narry Kim, M.S., D.Phil, Professor, Seoul National University
"Viral hijacking of host functions to protect viral RNA"
A recording is posted here.
July 16 - Andrew Vaillant, Ph.D., Chief Scientific Officer, Replicor Inc.
"Understanding HBsAg and subviral particles: key players in chronic HBV infection and key targets in achieving functional cure of HBV."
A recording is posted here.
June 30 - Marion Peters, M.D., University of California, San Francisco
Bruce Witte Distinguished Lecture, "Precision Medicine for Chronic Hepatitis B"
A recording is posted here.
June 18 - Scott L. Friedman, M.D., Icahn School of Medicine, N.Y.C.
"Mechanisms of Fibrosis Development in NAFLD and Therapeutic Strategies"
A recording is posted here.
June 4 - Mala Maini, M.D., University College, London
"Immunobiology of Chronic Hepatitis B"
A recording is posted here: